Protara (TARA) director awarded 31,000 options at $3.94 strike
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Protara Therapeutics director Roger Garceau received a grant of stock options for 31,000 shares of Common Stock. The options have an exercise price of $3.94 per share, expire on June 14, 2036, and vest in full on the first anniversary of the June 15, 2026 grant date or upon a Change of Control, subject to continued board service.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
GARCEAU ROGER
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 31,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 31,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 31,000 options
Exercise price: $3.94 per share
Underlying shares: 31,000 shares
+2 more
5 metrics
Options granted
31,000 options
Stock Option (Right to Buy) grant on June 15, 2026
Exercise price
$3.94 per share
Exercise price of granted stock options
Underlying shares
31,000 shares
Common Stock underlying the options
Total options after grant
31,000 options
Total derivative securities held after this transaction
Option expiration date
June 14, 2036
Expiration of stock options if unexercised
Key Terms
Stock Option (Right to Buy), Annual Grant, Change of Control, exercise price
4 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
Annual Grant financial
"The shares subject to the Annual Grant will vest in full"
Change of Control financial
"and will vest in full upon a Change of Control"
A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.
exercise price financial
"conversion_or_exercise_price: 3.9400"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What did Protara Therapeutics (TARA) director Roger Garceau receive in this Form 4?
Roger Garceau received a grant of stock options covering 31,000 shares of Protara Therapeutics Common Stock. These options were awarded as compensation and are not an open-market purchase or sale of existing shares.
What is the exercise price of Roger Garceau’s new Protara (TARA) stock options?
The granted stock options have an exercise price of $3.94 per share. This means Garceau can buy Protara Common Stock at $3.94 per share once the options are vested and exercised before expiration.
When do Roger Garceau’s Protara (TARA) stock options vest?
The options from the Annual Grant vest in full on the first anniversary of the June 15, 2026 grant date. Vesting is subject to his continuous service as a board member or will accelerate upon a Change of Control.
When do the Protara (TARA) stock options granted to Roger Garceau expire?
These stock options expire on June 14, 2036, if not exercised earlier. After this expiration date, Garceau can no longer exercise the options to purchase Protara Common Stock at the $3.94 exercise price.
How many Protara (TARA) options does Roger Garceau hold after this transaction?
Following this grant, Garceau holds 31,000 stock options according to the filing. This entire amount reflects the new Annual Grant, with no additional derivative holdings shown in this specific disclosure.